Article info
PDFClinical and epidemiological research
Extended report
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies
- Correspondence to Dr Jane E Salmon, Hospital for Special Surgery, New York, NY 10021, USA; salmonj{at}hss.edu
Citation
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies
Publication history
- Received August 11, 2017
- Revised December 7, 2017
- Accepted December 10, 2017
- First published January 25, 2018.
Online issue publication
March 12, 2018
Article Versions
- Previous version (25 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.